title: [Intrahospital management of women with preeclampsia].
abstract: The management of the PE patient requires admission in order to perform a meticulous assessment of the mothers' and fetal state, distinguishing between the severe and the mild forms. In moderate forms, the pregnancy is allowed to reach the 37(th) week of gestation. In severe forms of PE, the pregnancy is only allowed to continue under stringent monitoring. Before the 34(th) week of amenorrhea is reached, corticosteroid therapy and transfer to an adapted maternity are recommended. The true benefit provided by antihypertensive therapy in the moderate forms of PE is very limited. The presently recommended antihypertensive agent is nicardipine, which can be used in association with magnesium sulphate provided there is appropriate monitoring.
authors.affiliation: Service d'anesthésie-réanimation chirurgicale, hôpitaux universitaires de Strasbourg, hôpital de Hautepierre, avenue Molière, 67098 Strasbourg cedex, France. pierre.diemunsch@chru-strasbourg.fr
authors.forename: P
authors.initials: P
authors.lastname: Diemunsch
authors.forename: B
authors.initials: B
authors.lastname: Langer
authors.forename: E
authors.initials: E
authors.lastname: Noll
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D005260:Female; D005323:Fetal Monitoring; D006760:Hospitalization; D006801:Humans; D017616:Magnesium Compounds / Q000627:therapeutic use; D008991:Monitoring, Physiologic; D009529:Nicardipine / Q000627:therapeutic use; D011225:Pre-Eclampsia / Q000175:diagnosis / Q000628:therapy*; D011247:Pregnancy
chemical_list: D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D000959:Antihypertensive Agents; D017616:Magnesium Compounds; D009529:Nicardipine